Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets.

Wu C, Espinoza DA, Koelle SJ, Yang D, Truitt L, Schlums H, Lafont BA, Davidson-Moncada JK, Lu R, Kaur A, Hammer Q, Li B, Panch S, Allan DA, Donahue RE, Childs RW, Romagnani C, Bryceson YT, Dunbar CE.

Sci Immunol. 2018 Nov 2;3(29). pii: eaat9781. doi: 10.1126/sciimmunol.aat9781.

PMID:
30389798
2.

Innate lymphoid cells in lung infection and immunity.

Stehle C, Hernández DC, Romagnani C.

Immunol Rev. 2018 Nov;286(1):102-119. doi: 10.1111/imr.12712. Review.

PMID:
30294964
3.

Natural killer cell specificity for viral infections.

Hammer Q, Rückert T, Romagnani C.

Nat Immunol. 2018 Aug;19(8):800-808. doi: 10.1038/s41590-018-0163-6. Epub 2018 Jul 19. Review.

PMID:
30026479
4.

Boosting Type 2 Immunity: When OX40L Comes from ILC2s.

Babic M, Romagnani C.

Immunity. 2018 Jun 19;48(6):1067-1069. doi: 10.1016/j.immuni.2018.06.004.

PMID:
29924969
5.

The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity.

Babic M, Romagnani C.

Front Immunol. 2018 May 30;9:1219. doi: 10.3389/fimmu.2018.01219. eCollection 2018. Review.

6.

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.

Hammer Q, Rückert T, Borst EM, Dunst J, Haubner A, Durek P, Heinrich F, Gasparoni G, Babic M, Tomic A, Pietra G, Nienen M, Blau IW, Hofmann J, Na IK, Prinz I, Koenecke C, Hemmati P, Babel N, Arnold R, Walter J, Thurley K, Mashreghi MF, Messerle M, Romagnani C.

Nat Immunol. 2018 May;19(5):453-463. doi: 10.1038/s41590-018-0082-6. Epub 2018 Apr 9.

PMID:
29632329
7.

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma.

Schleussner N, Merkel O, Costanza M, Liang HC, Hummel F, Romagnani C, Durek P, Anagnostopoulos I, Hummel M, Jöhrens K, Niedobitek A, Griffin PR, Piva R, Sczakiel HL, Woessmann W, Damm-Welk C, Hinze C, Stoiber D, Gillissen B, Turner SD, Kaergel E, von Hoff L, Grau M, Lenz G, Dörken B, Scheidereit C, Kenner L, Janz M, Mathas S.

Leukemia. 2018 Sep;32(9):1994-2007. doi: 10.1038/s41375-018-0045-9. Epub 2018 Mar 28.

8.

Stable lines and clones of long-term proliferating normal, genetically unmodified murine common lymphoid progenitors.

Kawano Y, Petkau G, Stehle C, Durek P, Heinz GA, Tanimoto K, Karasuyama H, Mashreghi MF, Romagnani C, Melchers F.

Blood. 2018 May 3;131(18):2026-2035. doi: 10.1182/blood-2017-09-805259. Epub 2018 Mar 23.

PMID:
29572379
9.

CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells.

Stanko K, Iwert C, Appelt C, Vogt K, Schumann J, Strunk FJ, Ahrlich S, Schlickeiser S, Romagnani C, Jürchott K, Meisel C, Willimsky G, Kühl AA, Sawitzki B.

Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):E2940-E2949. doi: 10.1073/pnas.1708329115. Epub 2018 Mar 12.

10.

Adaptive Natural Killer Cells Integrate Interleukin-18 during Target-Cell Encounter.

Hammer Q, Rückert T, Dunst J, Romagnani C.

Front Immunol. 2018 Jan 17;8:1976. doi: 10.3389/fimmu.2017.01976. eCollection 2017.

11.

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

Cossarizza A, Chang HD, Radbruch A, Akdis M, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Borsellino G, Boulais PE, Brinkman RR, Büscher M, Busch DH, Bushnell TP, Cao X, Cavani A, Chattopadhyay PK, Cheng Q, Chow S, Clerici M, Cooke A, Cosma A, Cosmi L, Cumano A, Dang VD, Davies D, De Biasi S, Del Zotto G, Della Bella S, Dellabona P, Deniz G, Dessing M, Diefenbach A, Di Santo J, Dieli F, Dolf A, Donnenberg VS, Dörner T, Ehrhardt GRA, Endl E, Engel P, Engelhardt B, Esser C, Everts B, Dreher A, Falk CS, Fehniger TA, Filby A, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frenette PS, Galbraith D, Garbi N, García-Godoy MD, Geginat J, Ghoreschi K, Gibellini L, Goettlinger C, Goodyear CS, Gori A, Grogan J, Gross M, Grützkau A, Grummitt D, Hahn J, Hammer Q, Hauser AE, Haviland DL, Hedley D, Herrera G, Herrmann M, Hiepe F, Holland T, Hombrink P, Houston JP, Hoyer BF, Huang B, Hunter CA, Iannone A, Jäck HM, Jávega B, Jonjic S, Juelke K, Jung S, Kaiser T, Kalina T, Keller B, Khan S, Kienhöfer D, Kroneis T, Kunkel D, Kurts C, Kvistborg P, Lannigan J, Lantz O, Larbi A, LeibundGut-Landmann S, Leipold MD, Levings MK, Litwin V, Liu Y, Lohoff M, Lombardi G, Lopez L, Lovett-Racke A, Lubberts E, Ludewig B, Lugli E, Maecker HT, Martrus G, Matarese G, Maueröder C, McGrath M, McInnes I, Mei HE, Melchers F, Melzer S, Mielenz D, Mills K, Mirrer D, Mjösberg J, Moore J, Moran B, Moretta A, Moretta L, Mosmann TR, Müller S, Müller W, Münz C, Multhoff G, Munoz LE, Murphy KM, Nakayama T, Nasi M, Neudörfl C, Nolan J, Nourshargh S, O'Connor JE, Ouyang W, Oxenius A, Palankar R, Panse I, Peterson P, Peth C, Petriz J, Philips D, Pickl W, Piconese S, Pinti M, Pockley AG, Podolska MJ, Pucillo C, Quataert SA, Radstake TRDJ, Rajwa B, Rebhahn JA, Recktenwald D, Remmerswaal EBM, Rezvani K, Rico LG, Robinson JP, Romagnani C, Rubartelli A, Ruckert B, Ruland J, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sawitzki B, Scheffold A, Schiemann M, Schildberg F, Schimisky E, Schmid SA, Schmitt S, Schober K, Schüler T, Schulz AR, Schumacher T, Scotta C, Shankey TV, Shemer A, Simon AK, Spidlen J, Stall AM, Stark R, Stehle C, Stein M, Steinmetz T, Stockinger H, Takahama Y, Tarnok A, Tian Z, Toldi G, Tornack J, Traggiai E, Trotter J, Ulrich H, van der Braber M, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Volkmann K, Waisman A, Walker R, Ward MD, Warnatz K, Warth S, Watson JV, Watzl C, Wegener L, Wiedemann A, Wienands J, Willimsky G, Wing J, Wurst P, Yu L, Yue A, Zhang Q, Zhao Y, Ziegler S, Zimmermann J.

Eur J Immunol. 2017 Oct;47(10):1584-1797. doi: 10.1002/eji.201646632. No abstract available.

12.

OMIP-039: Detection and analysis of human adaptive NKG2C+ natural killer cells.

Hammer Q, Romagnani C.

Cytometry A. 2017 Oct;91(10):997-1000. doi: 10.1002/cyto.a.23168. Epub 2017 Jul 17. No abstract available.

13.

The ILC World Revisited.

Diefenbach A, Colonna M, Romagnani C.

Immunity. 2017 Mar 21;46(3):327-332. doi: 10.1016/j.immuni.2017.03.008.

14.

About Training and Memory: NK-Cell Adaptation to Viral Infections.

Hammer Q, Romagnani C.

Adv Immunol. 2017;133:171-207. doi: 10.1016/bs.ai.2016.10.001. Epub 2016 Nov 30. Review.

PMID:
28215279
15.

Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help.

Ni J, Hölsken O, Miller M, Hammer Q, Luetke-Eversloh M, Romagnani C, Cerwenka A.

Oncoimmunology. 2016 Aug 5;5(9):e1219009. eCollection 2016.

16.

Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal study.

Laginha I, Kopp MA, Druschel C, Schaser KD, Brommer B, Hellmann RC, Watzlawick R, Ossami-Saidi RR, Prüss H, Failli V, Meisel C, Liebscher T, Prilipp E, Niedeggen A, Ekkernkamp A, Grittner U, Piper SK, Dirnagl U, Killig M, Romagnani C, Schwab JM.

BMC Neurol. 2016 Sep 13;16:170. doi: 10.1186/s12883-016-0681-5.

17.

Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus.

Gerstner S, Köhler W, Heidkamp G, Purbojo A, Uchida S, Ekici AB, Heger L, Luetke-Eversloh M, Schubert R, Bader P, Klingebiel T, Koehl U, Mackensen A, Romagnani C, Cesnjevar R, Dudziak D, Ullrich E.

J Leukoc Biol. 2016 Dec;100(6):1297-1310. Epub 2016 Jun 28.

PMID:
27354408
18.

Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.

Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, Oei VYS, Schaffer M, Taskén K, Ljunggren HG, Romagnani C, Trowsdale J, Malmberg KJ, Béziat V.

Cell Rep. 2016 May 3;15(5):1088-1099. doi: 10.1016/j.celrep.2016.04.005. Epub 2016 Apr 21.

19.

Differentiation of human innate lymphoid cells (ILCs).

Juelke K, Romagnani C.

Curr Opin Immunol. 2016 Feb;38:75-85. doi: 10.1016/j.coi.2015.11.005. Epub 2015 Dec 17. Review.

PMID:
26707651
20.

Putting the brakes on ILC2 cells.

Stehle C, Saikali P, Romagnani C.

Nat Immunol. 2016 Jan;17(1):43-4. doi: 10.1038/ni.3353. No abstract available.

PMID:
26681462
21.

IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus.

Facciotti F, Gagliani N, Häringer B, Alfen JS, Penatti A, Maglie S, Paroni M, Iseppon A, Moro M, Crosti MC, Stölzel K, Romagnani C, Moroni G, Ingegnoli F, Torretta S, Pignataro L, Annoni A, Russo F, Pagani M, Abrignani S, Meroni P, Flavell R, Geginat J.

J Allergy Clin Immunol. 2016 Jan;137(1):318-321.e5. doi: 10.1016/j.jaci.2015.06.044. Epub 2015 Aug 25. No abstract available.

PMID:
26318071
22.

ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.

Paclik D, Stehle C, Lahmann A, Hutloff A, Romagnani C.

Eur J Immunol. 2015 Oct;45(10):2766-72. doi: 10.1002/eji.201545635. Epub 2015 Aug 31.

23.

Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.

Montaldo E, Juelke K, Romagnani C.

Eur J Immunol. 2015 Aug;45(8):2171-82. doi: 10.1002/eji.201545598. Epub 2015 Jun 18. Review.

24.

The 3 major types of innate and adaptive cell-mediated effector immunity.

Annunziato F, Romagnani C, Romagnani S.

J Allergy Clin Immunol. 2015 Mar;135(3):626-35. doi: 10.1016/j.jaci.2014.11.001. Epub 2014 Dec 18. Review.

PMID:
25528359
25.

Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.

Montaldo E, Teixeira-Alves LG, Glatzer T, Durek P, Stervbo U, Hamann W, Babic M, Paclik D, Stölzel K, Gröne J, Lozza L, Juelke K, Matzmohr N, Loiacono F, Petronelli F, Huntington ND, Moretta L, Mingari MC, Romagnani C.

Immunity. 2014 Dec 18;41(6):988-1000. doi: 10.1016/j.immuni.2014.11.010. Epub 2014 Nov 28.

26.

Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells.

Luetke-Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, Hamann A, Walter J, Chang HD, Dong J, Romagnani C.

PLoS Pathog. 2014 Oct 16;10(10):e1004441. doi: 10.1371/journal.ppat.1004441. eCollection 2014 Oct.

27.

IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.

Kastirr I, Maglie S, Paroni M, Alfen JS, Nizzoli G, Sugliano E, Crosti MC, Moro M, Steckel B, Steinfelder S, Stölzel K, Romagnani C, Botti F, Caprioli F, Pagani M, Abrignani S, Geginat J.

J Immunol. 2014 Oct 1;193(7):3322-31. doi: 10.4049/jimmunol.1400775. Epub 2014 Aug 29.

28.

Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantation.

Killig M, Friedrichs B, Meisig J, Gentilini C, Blüthgen N, Loddenkemper C, Labopin M, Basara N, Pfrepper C, Niederwieser DW, Uharek L, Romagnani C.

Eur J Immunol. 2014 Sep;44(9):2822-34. doi: 10.1002/eji.201444586. Epub 2014 Jun 30.

29.

NK cells gain higher IFN-γ competence during terminal differentiation.

Luetke-Eversloh M, Cicek BB, Siracusa F, Thom JT, Hamann A, Frischbutter S, Baumgrass R, Chang HD, Thiel A, Dong J, Romagnani C.

Eur J Immunol. 2014 Jul;44(7):2074-84. doi: 10.1002/eji.201344072. Epub 2014 May 19.

30.

Recognition strategies of group 3 innate lymphoid cells.

Killig M, Glatzer T, Romagnani C.

Front Immunol. 2014 Apr 1;5:142. doi: 10.3389/fimmu.2014.00142. eCollection 2014. Review.

31.

NK/DC crosstalk in immunosurveillance: a broken relationship caused by WASP-deficiency.

Romagnani C, Babic M.

Eur J Immunol. 2014 Apr;44(4):958-61. doi: 10.1002/eji.201444514.

32.

Signatures of human NK cell development and terminal differentiation.

Luetke-Eversloh M, Killig M, Romagnani C.

Front Immunol. 2013 Dec 30;4:499. doi: 10.3389/fimmu.2013.00499. Review.

33.

Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses.

Nizzoli G, Krietsch J, Weick A, Steinfelder S, Facciotti F, Gruarin P, Bianco A, Steckel B, Moro M, Crosti M, Romagnani C, Stölzel K, Torretta S, Pignataro L, Scheibenbogen C, Neddermann P, De Francesco R, Abrignani S, Geginat J.

Blood. 2013 Aug 8;122(6):932-42. doi: 10.1182/blood-2013-04-495424. Epub 2013 Jun 21.

34.

RORγt⁺ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44.

Glatzer T, Killig M, Meisig J, Ommert I, Luetke-Eversloh M, Babic M, Paclik D, Blüthgen N, Seidl R, Seifarth C, Gröne J, Lenarz M, Stölzel K, Fugmann D, Porgador A, Hauser A, Karlas A, Romagnani C.

Immunity. 2013 Jun 27;38(6):1223-35. doi: 10.1016/j.immuni.2013.05.013. Epub 2013 Jun 20.

35.

IMprinting of PAthogenic Memory in Berlin.

Romagnani C, Hauser A, Chang HD.

Eur J Immunol. 2013 Mar;43(3):572-5. No abstract available.

PMID:
23607107
36.

A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.

Schoenbrunn A, Frentsch M, Kohler S, Keye J, Dooms H, Moewes B, Dong J, Loddenkemper C, Sieper J, Wu P, Romagnani C, Matzmohr N, Thiel A.

J Immunol. 2012 Dec 15;189(12):5985-94. doi: 10.4049/jimmunol.1201090. Epub 2012 Nov 16.

37.

The early cellular signatures of protective immunity induced by live viral vaccination.

Kohler S, Bethke N, Böthe M, Sommerick S, Frentsch M, Romagnani C, Niedrig M, Thiel A.

Eur J Immunol. 2012 Sep;42(9):2363-73. doi: 10.1002/eji.201142306. Epub 2012 Aug 6.

39.

The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.

Pietra G, Romagnani C, Manzini C, Moretta L, Mingari MC.

J Biomed Biotechnol. 2010;2010:907092. doi: 10.1155/2010/907092. Epub 2010 Jun 22. Review.

40.

CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.

Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, Morandi B, Ferlazzo G, Thiel A, Schmitt-Knosalla I, Romagnani C.

Blood. 2010 Aug 26;116(8):1299-307. doi: 10.1182/blood-2009-11-253286. Epub 2010 May 26.

41.

HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.

Pietra G, Romagnani C, Moretta L, Mingari MC.

Curr Pharm Des. 2009;15(28):3336-44. Review.

PMID:
19860683
42.

Education of hyporesponsive NK cells by cytokines.

Juelke K, Killig M, Thiel A, Dong J, Romagnani C.

Eur J Immunol. 2009 Sep;39(9):2548-55. doi: 10.1002/eji.200939307.

43.

Cytokine-induced human IFN-gamma-secreting effector-memory Th cells in chronic autoimmune inflammation.

Sattler A, Wagner U, Rossol M, Sieper J, Wu P, Krause A, Schmidt WA, Radmer S, Kohler S, Romagnani C, Thiel A.

Blood. 2009 Feb 26;113(9):1948-56. doi: 10.1182/blood-2008-02-139147. Epub 2008 Dec 22.

44.

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R, Ratto G, Forte G, Carrega P, Lui G, Conte R, Strowig T, Moretta A, Münz C, Thiel A, Moretta L, Ferlazzo G.

J Immunol. 2007 Apr 15;178(8):4947-55.

45.

Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses.

Della Chiesa M, Romagnani C, Thiel A, Moretta L, Moretta A.

Blood. 2006 Dec 1;108(12):3851-8. Epub 2006 Jul 27.

46.

Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.

Romagnani C, Della Chiesa M, Kohler S, Moewes B, Radbruch A, Moretta L, Moretta A, Thiel A.

Eur J Immunol. 2005 Aug;35(8):2452-8.

47.

Post-thymic in vivo proliferation of naive CD4+ T cells constrains the TCR repertoire in healthy human adults.

Kohler S, Wagner U, Pierer M, Kimmig S, Oppmann B, Möwes B, Jülke K, Romagnani C, Thiel A.

Eur J Immunol. 2005 Jun;35(6):1987-94.

48.

HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.

Romagnani C, Pietra G, Falco M, Mazzarino P, Moretta L, Mingari MC.

Hum Immunol. 2004 May;65(5):437-45.

PMID:
15172443
49.
50.

Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells.

Pietra G, Romagnani C, Mazzarino P, Millo E, Moretta L, Mingari MC.

Eur J Immunol. 2003 Dec;33(12):3427-32.

Supplemental Content

Loading ...
Support Center